Atrial flutter and fibrillation in patients with chronic pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012
Pulmonary veno-occlusive disease as a consequence of catheter ablation of atrial fibrillation Source: Eur Respir J 2001; 18: Suppl. 33, 522s Year: 2001
OSA and atrial fibrillation Source: Sleep and Breathing Conference 2021 Year: 2021
Sinus venosus atrial septal defect in a 31-year-old female patient: a case for surgical repair Source: Eur Respir Rev 2010 19: 340-344 Year: 2010
Paroxysmal atrial fibrillation as a symptom of pulmonary embolism Source: Eur Respir J 2006; 28: Suppl. 50, 44s Year: 2006
Effect of atrial septostomy on the survival of patients with severe pulmonary arterial hypertension Source: Eur Respir J 2011; 38: 1343-1348 Year: 2011
Pulmonary vein stenosis (PVS) after radiofrequency ablation (RFA) for atrial fibrillation Source: Annual Congress 2009 - Lung infections; diagnostic and therapeutic problems Year: 2009
Pulmonary embolism in noncoagulated patients with chronic atrial fibrillation at admission Source: Eur Respir J 2006; 28: Suppl. 50, 44s Year: 2006
Right atrial enlargement and prognosis in the hemodinamically stable pulmonary embolism Source: Annual Congress 2012 - Pulmonary circulation: end-points and biomarkers Year: 2012
Right ventricular global strain and right ventricular dyssynchrony can predict success to pulmonary vasodilators therapy in PH patients Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models Year: 2012
Predictors of recurrence in patients undergoing cryoballoon ablation for treatment of atrial fibrillation: The independent role of sleep disordered breathing Source: Annual Congress 2011 - Physiology and cardiometabolic comorbidities in obstructive sleep apnoea Year: 2011
Long-term survival in pulmonary hypertension with atrial septostomy: a single center experience Source: Virtual Congress 2020 – Epidemiology and treatment of pulmonary arterial hypertension Year: 2020
Atrial natriuretic peptide as a serum marker of right atrial enlargement and function in pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012
Improving anticoagulation practice in respiratory patients with non-valvular atrial fibrillation Source: International Congress 2016 – The best clinical approach to lung diseases Year: 2016
Atrial septostomy in severe pulmonary hypertension - more than just a bridge to heart lung transplantation Source: Eur Respir J 2001; 18: Suppl. 33, 522s Year: 2001
Risk factors for asymptomatic atrial fibrillation in patients with COPD Source: International Congress 2018 – Cardiovascular morbidities in COPD Year: 2018
Anticoagulation in acute and chronic pulmonary embolism and atrial fibrillation Source: International Congress 2018 – PG19 Heart-lung interaction Year: 2018
Prediction of right ventricular dysfunction in patients with pulmonary embolism Source: Eur Respir J 2007; 30: Suppl. 51, 602s Year: 2007
Right and left ventricular dysfunction in patients with COPD and heart failure Source: Eur Respir J 2007; 30: Suppl. 51, 706s Year: 2007